TotalMarketCap

Akebia Therapeutics

AKBANasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$121.345 M

$0.44 -36.97%

Close of 6 Nov 2026

As of 6 Nov 2026, Akebia Therapeutics (AKBA) has a market capitalization of $121.3M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$236.2M

#2220 by revenue

Earnings

-$5.30M

Loss-making

Shares outstanding

277,663,875

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #276PDS BiotechnologyPDSB$123.9M
  2. #277Spruce BiosciencesSPRB$122.4M
  3. #278Akebia TherapeuticsAKBA$121.3M
  4. #279Journey MedicalDERM$121.2M
  5. #280BGM GroupBGM$118.9M

What if Akebia Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$101,899.09

Per share 232,699× higher

Bitcoin $1.53T

$5,513.58

Per share 12,591× higher

Apple $5.02T

$18,100.58

Per share 41,335× higher

Or at a round number

$200.0M$500.0M$1.00B$2.00B

Where these numbers come from

Share counts and financials for Akebia Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.